Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
This is the article text and summary supplied by the publisher’s RSS feed. The publisher may provide additional reporting, images or updates on its own website.
Continue to full story ↗